Evaluating the Factors Driving Market Expansion and Patient Adoption in the Non-Statin Segment
  The trajectory of growth in the Nexletol Market is primarily driven by the expanding recognition of statin intolerance as a major public health issue leading to poor patient adherence and sub-optimal LDL-C control. This growth is reflected in the increasing number of prescriptions written for non-statin oral therapies, particularly by specialist physicians seeking to provide effective...
0 Kommentare 0 Geteilt 41 Ansichten 0 Bewertungen
Lifesone https://lifesone.com